Aikido Pharma Inc expected to post a loss of 3 cents a share - Earnings Preview

Dominari Holdings

10/11/2021 02:45

* Aikido Pharma Inc  AIKI.OQ   AIKI.O  is expected to report
results on November 11 (estimated).
​* Refinitiv's mean analyst estimate for Aikido Pharma Inc is
for a loss of 3 cents per share. 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
​
* Wall Street's median 12-month price target for Aikido Pharma
Inc is $2​, about 58.7% above​ its last closing price
of $0.83. ​​​
This summary was machine generated November 10 at 02:45 GMT. 
All figures in US dollars  unless otherwise stated